Literature DB >> 7901167

A T cell-independent protective host response against Cryptococcus neoformans expressed at the primary site of infection in the lung.

J O Hill1, P L Dunn.   

Abstract

T cell-independent host resistance expressed against a primary lung infection with Cryptococcus neoformans was investigated. Following intratracheal inoculation of the yeast, BALB/cBy scid/scid mice or CD4+ plus CD8+ T cell-depleted BALB/cBy mice developed a primary lung infection that remained stable for several weeks before progressing and disseminating to kill the host. By contrast, normal BALB/cBy hosts resolved the infection after 4 to 8 weeks. Thy+ CD4- CD8- cells were found to accumulate in the pulmonary alveoli of infected scid/scid or normal mice. Depletion of these cells caused the infection to progress more rapidly and resulted 4 weeks later in a 30- to 70-fold increase in yeast numbers in the lungs and dissemination to extrapulmonary sites. Cytofluorometric studies revealed that the Thy+ CD4- CD8- cells responsible were negative for the CD3 T cell marker. A small percentage of these Thy+ CD3- cells expressed asialo-Gm1, but treatment with asialo-Gm1 antibody did not have the same infection-enhancing effect as Thy-1 monoclonal antibody treatment. Further experiments revealed that Thy-1 monoclonal antibody treatment had no effect on the establishment of infectious foci in the brain or liver following intravenous inoculation of the yeast. The data point to the existence of an early resistance mechanism for which Thy+ CD3- CD4- CD8- cells are essential. This mechanism of host defense, while insufficient for complete protection, may be capable of delaying the development of cryptococcal meningoencephalitis by restricting the growth of the yeast at primary sites of infection in the lungs, even in immunodeficient mice.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7901167      PMCID: PMC281315          DOI: 10.1128/iai.61.12.5302-5308.1993

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  21 in total

1.  Resolution of primary murine listeriosis and acquired resistance to lethal secondary infection can be mediated predominantly by Thy-1+ CD4- CD8- cells.

Authors:  P L Dunn; R J North
Journal:  J Infect Dis       Date:  1991-11       Impact factor: 5.226

2.  Early gamma interferon production by natural killer cells is important in defense against murine listeriosis.

Authors:  P L Dunn; R J North
Journal:  Infect Immun       Date:  1991-09       Impact factor: 3.441

3.  Murine natural killer cells are fungicidal to Cryptococcus neoformans.

Authors:  M R Hidore; N Nabavi; F Sonleitner; J W Murphy
Journal:  Infect Immun       Date:  1991-05       Impact factor: 3.441

4.  Phenotypic and functional characterization of human lymphocytes activated by interleukin-2 to directly inhibit growth of Cryptococcus neoformans in vitro.

Authors:  S M Levitz; M P Dupont
Journal:  J Clin Invest       Date:  1993-04       Impact factor: 14.808

5.  Latent infection of SCID mice with herpes simplex virus 1 and lethal cutaneous lesions in pregnancy.

Authors:  K Moriyama; S Mohri; T Watanabe; R Mori
Journal:  Microbiol Immunol       Date:  1992       Impact factor: 1.955

6.  Poly(I.C)-induced interferons enhance susceptibility of SCID mice to systemic candidiasis.

Authors:  J Jensen; A Vazquez-Torres; E Balish
Journal:  Infect Immun       Date:  1992-11       Impact factor: 3.441

7.  Secondary Echinococcus multilocularis infection in severe combined immunodeficient (scid) mice: biphasic growth of the larval cyst mass.

Authors:  M C Playford; H K Ooi; Y Oku; M Kamiya
Journal:  Int J Parasitol       Date:  1992-11       Impact factor: 3.981

8.  T cell-mediated immunity in the lung: a Cryptococcus neoformans pulmonary infection model using SCID and athymic nude mice.

Authors:  G B Huffnagle; J L Yates; M F Lipscomb
Journal:  Infect Immun       Date:  1991-04       Impact factor: 3.441

9.  CD4+ T cells cause multinucleated giant cells to form around Cryptococcus neoformans and confine the yeast within the primary site of infection in the respiratory tract.

Authors:  J O Hill
Journal:  J Exp Med       Date:  1992-06-01       Impact factor: 14.307

10.  Intrapulmonary growth and dissemination of an avirulent strain of Cryptococcus neoformans in mice depleted of CD4+ or CD8+ T cells.

Authors:  J O Hill; A G Harmsen
Journal:  J Exp Med       Date:  1991-03-01       Impact factor: 14.307

View more
  8 in total

1.  Induction of interleukin-12 and gamma interferon requires tumor necrosis factor alpha for protective T1-cell-mediated immunity to pulmonary Cryptococcus neoformans infection.

Authors:  Amy C Herring; John Lee; Roderick A McDonald; Galen B Toews; Gary B Huffnagle
Journal:  Infect Immun       Date:  2002-06       Impact factor: 3.441

Review 2.  Immune response and immunotherapy to Cryptococcus infections.

Authors:  Qing Zhou; William J Murphy
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

3.  Antifungal therapy in a murine model of disseminated infection by Cryptococcus gattii.

Authors:  Enrique Calvo; F Javier Pastor; M Mar Rodríguez; Isabel Pujol; Josep Guarro
Journal:  Antimicrob Agents Chemother       Date:  2010-07-12       Impact factor: 5.191

4.  The absence of serum IgM enhances the susceptibility of mice to pulmonary challenge with Cryptococcus neoformans.

Authors:  Krishanthi S Subramaniam; Kausik Datta; Eric Quintero; Catherine Manix; Matthew S Marks; Liise-Anne Pirofski
Journal:  J Immunol       Date:  2010-04-19       Impact factor: 5.422

Review 5.  Role of dendritic cell-pathogen interactions in the immune response to pulmonary cryptococcal infection.

Authors:  Alison J Eastman; John J Osterholzer; Michal A Olszewski
Journal:  Future Microbiol       Date:  2015       Impact factor: 3.165

6.  Pathogenesis of pulmonary Cryptococcus neoformans infection in the rat.

Authors:  D Goldman; S C Lee; A Casadevall
Journal:  Infect Immun       Date:  1994-11       Impact factor: 3.441

7.  Encapsulation of Cryptococcus neoformans regulates fungicidal activity and the antigen presentation process in human alveolar macrophages.

Authors:  A Vecchiarelli; D Pietrella; M Dottorini; C Monari; C Retini; T Todisco; F Bistoni
Journal:  Clin Exp Immunol       Date:  1994-11       Impact factor: 4.330

Review 8.  The regulation of pulmonary immunity.

Authors:  M F Lipscomb; D E Bice; C R Lyons; M R Schuyler; D Wilkes
Journal:  Adv Immunol       Date:  1995       Impact factor: 3.543

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.